Comparing the effectiveness of different treatment modalities on the smoking cessation rates;Farkli tedavi yöntemlerinin sigara birakma başarisi üzerine etkileri

Tuberkuloz ve Toraks

Volumn 58, Issue 4, 2010, Pages 385-392

  Önen, Zeynep Pinar ^a   Şen, Elif ^a   Eriş Gülbay, Banu ^a   Öztürk, Ayperi ^a   Akkoca Yildiz, Öznur ^a   Acican, Turan ^a   Saryal, Sevgi ^a   Karabiyikoǧlu, Gülseren ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Behavioral treatments; Bupropion; Nicotine replacement treatment; Smoking cessation

Indexed keywords

AMFEBUTAMONE; CARBON MONOXIDE;

ADULT; AIRWAY OBSTRUCTION; ARTICLE; BEHAVIOR THEORY; COMORBIDITY; COMPARATIVE STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NICOTINE REPLACEMENT THERAPY; PREVALENCE; PROSPECTIVE STUDY; SMOKING CESSATION; SOCIAL ASPECT; TOBACCO DEPENDENCE;

ADULT; BUPROPION; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; NICOTINE; PSYCHOTHERAPY, GROUP; SMOKING CESSATION; TOBACCO USE DISORDER; TREATMENT OUTCOME;

EID: 78651403405     PISSN: 04941373     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. WHO tobacco free initiative. Building blocks for tobacco control: a handbook Geneva Switzerland: World WHO organization 2004.
2. Mathers CD, Loncar D. Projection of global mortality and burden of disease from 2002 to 2030 PLos Med 2006; 3: e442.
3. Edwards R. The problem of tobacco smoking. BMJ 2004; 328: 217-9.
4. Tønnesen P, Carrozzi L, Fagerström KO, et al. Smoking cessation in patients with respiratory diseases: a high priority, integral component of therapy. Eur Respir J 2007; 29: 390-417.
5. Ezzati M, Lopez AD. Regional, disease specific patterns of smoking attributable-mortality in 2000. Control 2004; 13: 388-395.
6. Ezzati M, Henley SJ, Thun MJ, Lopez AD. Role of smoking in global and regional cardiovascular mortality. Circulation 2005; 112: 489-497.
7. Ezzati M, Henley SJ, Lopez AD, Thun MJ. Role of smoking in global and regional cancer epidemiology: current patterns and data needs. Int J Cancer 2005; 116: 963-971.
8. Global strategy for the diagnosis, management and prevention of COPD 2009. http://www.goldcopd.org site-sinden ulaşilabilir (Erişim tarihi 18.03.2010).
9. Centers for Disease Control and Prevention. Cigarette smoking among adults United States, 2006. MMWR Morb Mortal Wkly Rep 2007; 56: 1157-1161.
10. Office for National Statistics. Smoking-related behaviour and attitudes. 2008. www.statistics.gov.uk/downloads/theme-health/Smoking2005.pdf.
11. West R, Sohal T. "Catastrophic" pathways to smoking cessation: findings from national survey. BMJ 2006; 332: 458-60.
12. Anderson JE, Jorenby DE, Scott WJ, Fiore MC. Treating tobacco use and dependence:an evidence based clinical practice guideline for tobacco cessation. Chest 2002; 121: 932-941.
13. Uyar M, Bayram N, Filiz A, et al. Comparison of nicotine patch and bupropion in treating tobacco dependence. Eur Respir J 2005; 26(Suppl 49): 388s.
14. McEwen A, West R. Do implementation issues influence the effectiveness of medications? The case of nicotine replacement therapy and bupropion in UK Stop Smoking Services. BMC Public Health 2009; 21; 9:28.
15. Hughes JR, Carpenter MJ. Does smoking reduction increase future cessation and decrease disease risk? A qualitative review. Nicotine Tob Res 2006; 8: 739-49.
16. Stead LF, Lancaster T. Group behavior therapy programmes for smoking cessation. Cochrane Database Syst Rev. 2005; 2: CD001007.
17. Silagy C, Lncaster T, Stead L, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2004; 3: CD000146.
18. Hajek P, West R, Foulds J, et al. Randomized comparative trial of nicotine polacrilex, a transdermal patch, nasal spray, and an inhaler. Arch Intern Med 1999; 159: 2033-8. (Pubitemid 29453591)
19. West R, Hajek P, Nilsson F, et al. Individual differences in preferences for and responses to four nicotine replacement products. Psychopharmacology (Berl) 2001; 153: 225-30. (Pubitemid 32127891)
20. Uzaslan E. Sigarayi birakma yöntemleri. Ed; Özyardimci N (editör). Sigara ve Saǧlik. Bursa: 2002: 429-60.
21. Kilinç O. Sigara birakma tedavisinde davranişçi ve bilişsel yöntemler. In: Aytemur ZA, Akçay Ş ve Elbek O. Tütün ve Tütün Kontrolü. İstanbul: AVES Yayincilik, 2010: 479-484.
22. Demir T. Farmakolojik tedavi I. In: Aytemur ZA, Akçay Ş ve Elbek O. Tütün ve Tütün Kontrolü. İstanbul: AVES Yayincilik, 2010: 460-6.
23. Uzaslan E. Farmakolojik tedavi II. In: Aytemur ZA, Akçay Ş ve Elbek O. Tütün ve Tütün Kontrolü. İstanbul: AVES Yayincilik, 2010: 467-73.
24. DeGraff AC. Pharmacologic therapy for nicotine addiction. Chest 2002; 122: 392-4.
25. Dierker LC, Avenevoli S, Stolar M, Merikangas KR. Smoking and depression: an examination of mechanisms of comorbidity. Am J Psychiatry 2002; 159: 947-53.
26. Glassman AH, Covey LS, Stetner F, Rivelli S. Smoking cessation and the source of major depression: a follow up study. Lancet 2001; 357: 1929-32.
27. Covey LS, Glassman AH, Stetner F. Cigarette smoking and major depression. J Addict Dis 1998; 17: 35-46.